179 related articles for article (PubMed ID: 12415080)
1. Prostate cancer.
Mazhar D; Waxman J
Postgrad Med J; 2002 Oct; 78(924):590-5. PubMed ID: 12415080
[TBL] [Abstract][Full Text] [Related]
2. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
3. Localised prostate cancer - current treatment options.
Duchesne G
Aust Fam Physician; 2011 Oct; 40(10):768-71. PubMed ID: 22003477
[TBL] [Abstract][Full Text] [Related]
4. Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review.
Artibani W; Porcaro AB; De Marco V; Cerruto MA; Siracusano S
Urol Int; 2018; 100(3):251-262. PubMed ID: 29161715
[TBL] [Abstract][Full Text] [Related]
5. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer: a practical approach to current management of recurrent disease.
Walczak JR; Carducci MA
Mayo Clin Proc; 2007 Feb; 82(2):243-9. PubMed ID: 17290734
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, management and screening of early localised prostate cancer.
Selley S; Donovan J; Faulkner A; Coast J; Gillatt D
Health Technol Assess; 1997; 1(2):i, 1-96. PubMed ID: 9414541
[TBL] [Abstract][Full Text] [Related]
8. Is prostate cancer screening responsible for the negative results of prostate cancer treatment trials?
Prasad V
Med Hypotheses; 2016 Aug; 93():71-3. PubMed ID: 27372859
[TBL] [Abstract][Full Text] [Related]
9. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
Grossfeld GD; Li YP; Lubeck DP; Broering JM; Mehta SS; Carroll PR
J Urol; 2002 Aug; 168(2):530-5. PubMed ID: 12131303
[TBL] [Abstract][Full Text] [Related]
10. [Controversy over treatment options in clinical T3 prostate cancer].
Nishimura K; Yamamoto Y; Nakayama M; Kakimoto K
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2548-52. PubMed ID: 22189219
[TBL] [Abstract][Full Text] [Related]
11. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.
Mayer FJ; Crawford ED
Urol Clin North Am; 1994 Nov; 21(4):707-15. PubMed ID: 7974899
[TBL] [Abstract][Full Text] [Related]
12. The challenge of locally advanced prostate cancer.
Pisters LL
Semin Oncol; 1999 Apr; 26(2):202-16. PubMed ID: 10597731
[TBL] [Abstract][Full Text] [Related]
13. [Treatment option for pT3 patient after radical prostatectomy].
Sugimura Y; Wakita T; Mizogam A
Hinyokika Kiyo; 2005 Sep; 51(9):571-3. PubMed ID: 16229368
[TBL] [Abstract][Full Text] [Related]
14. Differences in Treatment and Outcome After Treatment with Curative Intent in the Screening and Control Arms of the ERSPC Rotterdam.
Bokhorst LP; Kranse R; Venderbos LD; Salman JW; van Leenders GJ; Schröder FH; Bangma CH; Roobol MJ;
Eur Urol; 2015 Aug; 68(2):179-82. PubMed ID: 25457496
[TBL] [Abstract][Full Text] [Related]
15. Locally advanced prostate cancer: current controversies and optimisation opportunities.
Sridharan S; Dal Pra A; Catton C; Bristow RG; Warde P
Clin Oncol (R Coll Radiol); 2013 Aug; 25(8):499-505. PubMed ID: 23680106
[TBL] [Abstract][Full Text] [Related]
16. Localised carcinoma of the prostate: a paradigm of uncertainty.
Sandhu SS; Kaisary AV
Postgrad Med J; 1997 Nov; 73(865):691-6. PubMed ID: 9519179
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the use of early hormonal therapy in patients with localised or locally advanced prostate cancer.
Kaisary AV
Prostate Cancer Prostatic Dis; 2005; 8(2):140-51. PubMed ID: 15852051
[TBL] [Abstract][Full Text] [Related]
18. Oncologic outcomes at 10 years following robotic radical prostatectomy.
Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
[TBL] [Abstract][Full Text] [Related]
19. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
Obata H; Shiota M; Akitake N; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M
Anticancer Res; 2017 Oct; 37(10):5631-5637. PubMed ID: 28982880
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer.
Wolff RF; Ryder S; Bossi A; Briganti A; Crook J; Henry A; Karnes J; Potters L; de Reijke T; Stone N; Burckhardt M; Duffy S; Worthy G; Kleijnen J
Eur J Cancer; 2015 Nov; 51(16):2345-67. PubMed ID: 26254809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
